Startups
The Nuclein PCR device is a rapid, handheld, low cost, all-in-one test for infectious disease diagnosis that delivers sample-to-answer within one hour.
Overview
Employees
11-50
Total raised
$14M
Founded date
2017
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 25, 2021 | Nuclein Closes $14M in Funding led by Trinity Private Equity Group | AUSTIN, Texas, March 25, 2021 /PRNewswire/ -- Nuclein, LLC has closed a $14 million Series B funding round. The financing helps Nuclein, a medical device company, to commercialize its novel, hand-held PCR platform designed as a disposable, ... |
| Mar 25, 2021 | Nuclein Closes $14M in Funding led by Trinity Private Equity Group | |
| Nuclein | ||
| Nuclein | “The Nuclein PCR device is a rapid, handheld, low cost, all-in-one test for infectious disease diagnosis that delivers sample-to-answer within one hour.” |
Reviews 0
FAQ about Nuclein™ Hand
When was Nuclein™ Hand founded?
Nuclein™ Hand was founded in 2017.
How much funding has Nuclein™ Hand raised?
Nuclein™ Hand has raised $14M in total across 1 funding round.
What has the press written about Nuclein™ Hand?
Parsers VC has collected 5 articles mentioning Nuclein™ Hand, among them “Nuclein Closes $14M in Funding led by Trinity Private Equity Group” (Mar 25, 2021) and “Nuclein Closes $14M in Funding led by Trinity Private Equity Group” (Mar 25, 2021).
Is Nuclein™ Hand still active?
Yes, Nuclein™ Hand is active; its latest activity on Parsers VC dates from Apr 2, 2021.